日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China

多替努拉与非布司他治疗痛风的疗效和安全性比较:一项在中国开展的随机、多中心、双盲3期临床试验

Sun, Jia; Wang, Yu; Cheng, Yongjing; Guo, Dongmei; Hu, Jiankang; Liu, Dongzhou; Gao, Zhengnan; Li, Changgui; Lu, Yibing; Kong, Xiaodan; Liu, Yu; Jiang, Zhenyu; Yi, Bin; Zhang, Hongfeng; Xu, Baijie; Yu, Shihao; Kokan, Rieko; Ishikawa, Kohei; Kawakatsu, Mikiko; Zhang, Zhuoli

Clinical Practice Consensus Statement 2025: Management of Hyperuricemia and Gout in Adolescents

2025年临床实践共识声明:青少年高尿酸血症和痛风的管理

Li, Changgui; Lu, Jie; Lyu, Zhaohui; Chen, Haibing; Su, Benli; Ban, Bo; Mao, Jianhua; Liu, Ping; Cheng, Zhifeng; Zhu, Jun; Wan, Naijun; Chen, Xiaobo; Gong, Chunxiu; Ye, Peiyu; Sun, Mingshu; Sun, Wenyan; Zhang, Hui; Yin, Han; Jiang, Xiaoyun; Wang, Qing; Chen, Yaolong; Lin, Hsiao-Yi; Mi, Jie; Zhao, Jiajun

Predictors of Inadequate Serum Urate Response to Low-Dose Febuxostat in Male Patients with Gout

预测男性痛风患者对低剂量非布司他治疗血清尿酸反应不足的因素

Sun, Wenyan; Zhao, Xuetong; Dalbeth, Nicola; Terkeltaub, Robert; Cui, Lingling; Liu, Zhen; Han, Lin; Wang, Can; Zhang, Hui; Bao, Yiming; Li, Changgui; Lu, Jie

Quantitative Assessment of Baseline Serum HDL-C to Predict Gout Flares During Urate-Lowering Therapy Initiation: A Prospective Cohort Study

定量评估基线血清高密度脂蛋白胆固醇水平以预测降尿酸治疗初期痛风发作:一项前瞻性队列研究

Jiang, Chang; Li, Maichao; Chen, Ying; He, Yuwei; Li, Xinde; Cui, Lingling; Qi, Han; Cheng, Zan; Zhang, Xiaoqing; Li, Changgui; Lu, Jie

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study

血清尿酸水平降低对中国男性痛风患者在开始降尿酸治疗期间痛风发作风险的影响:一项前瞻性队列研究

Pang, Lei; Xue, Xiaomei; He, Yuwei; Wang, Can; Han, Lin; Li, Maichao; Qi, Han; Li, Changgui; Lu, Jie

Assessment of plasma microRNAs in congenital intestinal malrotation

先天性肠旋转不良患者血浆微RNA的评估

Xiurui Lv ,Huan Chen ,Xinhe Sun ,Lingling Zhou ,Changgui Lu ,Hongxing Li

Long non-coding RNA FAL1 functions as a ceRNA to antagonize the effect of miR-637 on the down-regulation of AKT1 in Hirschsprung's disease

长链非编码 RNA FAL1 作为 ceRNA 拮抗 miR-637 对先天性巨结肠中 AKT1 下调的影响

Yang Li, Lingling Zhou, Changgui Lu, Qiyang Shen, Yang Su, Zhengke Zhi, Feng Wu, Hua Zhang, Zechao Wen, Guanglin Chen, Hongxing Li, Yankai Xia, Weibing Tang

Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease

鉴定出两种与先天性巨结肠相关的新型 PCDHA9 突变

Qiyang Shen, Hua Zhang, Yang Su, Zechao Wen, Zhongxian Zhu, Guanglin Chen, Lei Peng, Chunxia Du, Hua Xie, Hongxing Li, Xiaofeng Lv, Changgui Lu, Yankai Xia, Weibing Tang